ARCHIVES

Conversation with The Cancer Letter: Rosen’s New Role Is Part Of An Evolution Of Administrative Structure at City of Hope

This article is from The Cancer Letter archive.

Vol. 39 No. 41 | November 1, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993